EN

QART Medical and its cofounder, Natan Shaked, Featured in Haaretz Article Showcasing Improvement in Pregnancy Rates

QART Medical, its cofounder Professor Natan Shaked, and the Barzilay Medical Center IVF clinical team, Featured in Haaretz Article Showcasing Groundbreaking Technology

 

QART Medical is proud to share that its cofounder, Professor Natan Shaked, was recently featured in an article in Haaretz. The article highlights Professor Shaked’s pioneering leadership in the field and how QART Medical’s cutting-edge technology is poised to reshape the IVF industry.

In the article, Professor Shaked shares how QART’s innovative approach to quantitative phase microscopy allows for the imaging and analyzing of otherwise transparent sperm cells in a clinical setting – a paradigm shift that could allow IVF success rates to double. “We are thrilled that our work is gaining recognition in a respected publication like Haaretz,” said Professor Shaked. “This is a testament to our team’s hard work and the transformative potential of our technology. I am excited for what comes next as we continue to innovate and expand our reach.”

To read the article on the Haaretz website (account required) please click here.
For a PDF of the Hebrew version of the story please click here.

To read the article on the English website (account required) please click here.
For a PDF of the English version of the story please click here.

 

QART Medical is an ISO13485 certified MedTech company addressing the global infertility epidemic. To do so, QART has developed the Q300™, a breakthrough solution to male infertility issues that provides a quantitative characterization of sperm cell morphology to facilitate informed clinical decision making when selecting cells for use in in-vitro fertilization (IVF). QART aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by quantitatively characterizing the morphology and composition of individual sperm cells with 3D imaging. The Q300™ is registered with the US FDA, has received Israeli regulatory registration for commercial sales, and bears the CE (Conformité Européenne) Mark.